More articles from Letters to the Editor
- Prostate cancer screening
The costs of PSA testing—both financial and to the patient’s well-being—are not worth it.
Detection does not lead to overtreatment.
The costs of PSA testing—both financial and to the patient’s well-being—are not worth it.
Screening should be advised only if benefits clearly outweigh the risks